India Immunology Drugs Market Size and Forecast 2033

India Immunology Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A31318

Buy Now Discount
Offer

India Immunology Drugs Market Overview:

The India immunology drugs market size reached USD 2.52 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.04 Billion by 2033, exhibiting a growth rate (CAGR) of 7.40% during 2025-2033. The market is expanding at a rapid pace because of rising autoimmune conditions and growing awareness of treatment possibilities. Moreover, increased healthcare access, innovative drug development, and government subsidies are inducing market growth. Also, biological treatments and advanced diagnostics are driving the trend.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 2.52 Billion
Market Forecast in 2033	USD 5.04 Billion
Market Growth Rate 2025-2033	7.40%

India Immunology Drugs Market Trends:

Expansion of Diagnostics and Personalized Medicine

Diagnostic technologies and personalized medicine are transforming the market of immunology drugs in India. Also, there has been a heightened demand for accurate diagnostics that allow for customized treatment protocols due to an increasing incidence of autoimmune diseases. In line with this personalized medicine, Crohn's Mind genetic profiles, biomarkers, and unique health status facilitate better and targeted treatments. This strategy enhances patient outcomes and minimizes the risk of drug-related adverse reactions. Advances in diagnostic technologies, including advanced imaging and biomarker-based assays, are assisting doctors in determining the best immunotherapy treatments for patients. Similarly, the precision medicine trend is underpinned by growing investments in healthcare infrastructure and biotechnology advances. Furthermore, the market for immunology drugs is ready for further growth with advancing diagnostic services and the availability of personalized treatment solutions. Growing awareness among both healthcare professionals and patients regarding the need for personalized treatment is behind this movement, thereby making immunology drugs more available and efficient in treating a range of autoimmune diseases.

India Immunology Drugs Market Size

Growing Demand for Biologic Immunology Drugs

The Indian market has witnessed rising demand for biologic drugs, particularly monoclonal antibodies and immune checkpoint inhibitors. Moreover, these emerging therapies have significant advantages in autoimmune disease treatment, such as rheumatoid arthritis, multiple sclerosis, and Crohn's disease, due to their specificity and effectiveness in controlling the immune system. Patients are increasingly opting for such therapies because they are most effective, relatively free from side effects, and increasingly available targeted therapies. With providers of healthcare increasingly advocating biologic therapies over traditional drugs, the market has been seeing a quick shift to this sector. Further, innovation in biotechnology and investments in research have helped bring the cost of manufacturing biologics down, making them affordable to the general public. In September 2024, Indian Immunologicals Limited launched a pediatric dose of its Indigenous Hepatitis A vaccine, Havisure (0.5 ml), which bolstered the immunology drugs market by increasing vaccine accessibility, particularly for children. This move reinforced IIL’s role in India’s self-sufficiency in immunology products and helped expand the immunology drug landscape. Government policies supporting innovative drug approvals and manufacturing also play a crucial role in promoting biological treatments in the country.

India Immunology Drugs Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on drug class, indication, and end user.

Drug Class Insights:

Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine Therapies
Immunosuppressive Medication
Others

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes monoclonal antibodies (mAb), antibody drug conjugates, interferon and cytokine therapies, immunosuppressive medication, and others.

Indication Insights:

Arthritis
Plaque Psoriasis
Spondylitis
Inflammatory Bowel Disease
Transplant Rejection
Others

The report has provided a detailed breakup and analysis of the market based on the indication. This includes arthritis, plaque psoriasis, spondylitis, inflammatory bowel disease, transplant rejection, and others.

End User Insights:

Hospitals and Clinics
Cancer Research Institute
Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, cancer research institute, and others.

Regional Insights:

North India
South India
East India
West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Immunology Drugs Market News:

February 2025: Sanofi’s Rezurock (Belumosudil Tablets) received marketing approval in India for treating chronic graft-versus-host disease (cGVHD). This breakthrough therapy offers a new treatment option for patients with limited options, enhancing India’s immunology drugs segment by addressing critical unmet needs in transplant care.
January 2025: Emcure Pharmaceuticals launched its Emcure Research Centre in Ahmedabad, Gujarat, focusing on complex drug delivery systems, including advanced immunology drug formulations like sustained-release therapies and liposomal injections. This development is expected to accelerate innovations in immunology drugs.

India Immunology Drugs Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Drug Class Indication End User Region
Drug Classes Covered	Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine Therapies, Immunosuppressive Medication, Others
Indications Covered	Arthritis, Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant Rejection, Others
End Users Covered	Hospitals, Clinics, Cancer Research Institute, Others
Regions Covered	North India, South India, East India, West India
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India immunology drugs market performed so far and how will it perform in the coming years?
what is the breakup of the India immunology drugs market on the basis of drug class?
what is the breakup of the India immunology drugs market on the basis of indication?
what is the breakup of the India immunology drugs market on the basis of end user?
What are the various stages in the value chain of the India immunology drugs market?
What are the key driving factors and challenges in the India immunology drugs market?
What is the structure of the India immunology drugs market and who are the key players?
What is the degree of competition in the India immunology drugs market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India immunology drugs market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the India immunology drugs market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India immunology drugs industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.